Fludarabine phosphate
99%
- Product Code: 62006
CAS:
75607-67-9
| Molecular Weight: | 365.21 g./mol | Molecular Formula: | C₁₀H₁₃FN₅O₇P |
|---|---|---|---|
| EC Number: | MDL Number: | MFCD00866418 | |
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | 2~8℃ |
Product Description:
Fludarabine phosphate is primarily used in the treatment of certain types of cancer, particularly chronic lymphocytic leukemia (CLL). It is a chemotherapy drug that works by interfering with the growth and spread of cancer cells in the body. This medication is often administered when other treatments have not been effective. It is also used in conditioning regimens prior to hematopoietic stem cell transplantation, helping to prepare the body for the transplant by suppressing the immune system. Fludarabine phosphate is typically given intravenously and requires careful monitoring by healthcare professionals to manage potential side effects, which can include lowered blood cell counts and increased risk of infections.
Product Specification:
| Test | Specification |
|---|---|
| PURITY HPLC | 99 100% |
| APPEARANCE | WHITE TO LIGHT YELLOW POWDER |
| INFRARED SPECTRUM | Conforms to Structure |
| SOLUBILITY | COLORLESS CLEAR,0.95-1.05 MG/ML IN DMSO |
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.250 | 10-20 days | ฿5,200.00 |
+
-
|
| 1.000 | 10-20 days | ฿17,600.00 |
+
-
|
Fludarabine phosphate
Fludarabine phosphate is primarily used in the treatment of certain types of cancer, particularly chronic lymphocytic leukemia (CLL). It is a chemotherapy drug that works by interfering with the growth and spread of cancer cells in the body. This medication is often administered when other treatments have not been effective. It is also used in conditioning regimens prior to hematopoietic stem cell transplantation, helping to prepare the body for the transplant by suppressing the immune system. Fludarabine phosphate is typically given intravenously and requires careful monitoring by healthcare professionals to manage potential side effects, which can include lowered blood cell counts and increased risk of infections.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :